A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Lovaza for the Prevention of Recurrent, Symptomatic Atrial Fibrillation
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Lovaza for the Prevention of Recurrent, Symptomatic Atrial Fibrillation
The purpose of this study is to evaluate efficacy and safety of Omacor (omega-3-acid ethyl esters) in patients with recurrent, symptomatic atrial fibrillation.
Inclusion Criteria:
Exclusion Criteria:
Alamada, California 94501, United States
Fort Meyers, Florida 33919, United States
Mineappolis, Minnesota 55417, United States
Rochester Hills, Minnesota 48307, United States
Corvalis, Oregon 97330, United States